First-time bisphosphonate users at higher risk for eye diseases

04/3/2012 |

A study published online in the Canadian Medical Association Journal found that oral bisphosphonate use increases first-time users' risk of developing uveitis and scleritis compared with nonusers. Researchers studied 934,147 patients and found that the incidence of uveitis in first-time bisphosphonate users was 29 per 10,000 person-years versus 20 per 10,000 in nonusers, while the incidence of scleritis was 63 per 10,000 person-years in first-time users versus 36 per 10,000 in nonusers.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX